Histological findings and pathologic diagnosis of spiradenocarcinoma: A case series and review of the literature
- 27 December 2018
- journal article
- review article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 46 (4) , 243-250
Abstract
Background: Atypical spiradenoma and spiradenocarcinoma present a diagnostic challenge. We aim to assess the significance of certain histologic features, which may facilitate diagnosis of these tumors.Methods: A natural language search for cases of “atypical spiradenoma” and “spiradenocarcinoma” diagnosed between 2009 and 2018 was performed. Original slides were retrieved and a subset of cases (n = 5) were stained for Ki‐67, p53, carcinoembryonic antigen (CEA), and S100. All cases (n = 7) were assessed for overall architecture, atypical mitotic figures, abnormal cytology, necrosis, ductal proliferation, dilated vessels, and loss of dual cell population.Results: All our cases showed an abrupt transition from benign to malignant morphology, nuclear atypia, atypical mitotic figures, and a monomorphic loss of the dual cell population (7/7; 100%). The majority also had dilated vessels (6/7; 85.7%), and ductal dilation or proliferation (5/7; 71.4%). Fewer cases showed tumor encapsulation (3/7; 43%), massive necrosis (3/7; 43%), and focal cellular necrosis (1/7; 14%). All cases showed a relatively increased Ki‐67 proliferation index at the transitional interface (5/5; 100%). Almost all cases stained positively for p53 (4/5; 80%). Malignant areas of tumor or at the transitional interface showed more intense S100 staining (3/5; 60%). All cases were negative for CEA.Conclusion: Histologic features that strongly favor atypical spiradenoma or spiradenocarcinoma include abrupt transition to malignant foci, atypical mitotic figures, and monomorphic loss of the dual cell population. Ki‐67, p53, and S100 may help delineate areas of atypical or malignant transformation in spiradenomas.Keywords
This publication has 24 references indexed in Scilit:
- Giant Vascular Eccrine SpiradenomaAnnals of Dermatology, 2011
- Expression of p53 and TP53 Mutational Analysis in Malignant Neoplasms Arising in Preexisting Spiradenoma, Cylindroma, and Spiradenocylindroma, Sporadic or Associated with Brooke-Spiegler SyndromeThe American Journal of Dermatopathology, 2010
- External auditory canal eccrine spiradenocarcinoma: A case report and review of literatureHead & Neck, 2003
- Malignant Eccrine Spiradenoma (Spiradenocarcinoma)The American Journal of Dermatopathology, 2000
- Glycoproteins of the Carcinoembryonic Antigen (CEA) Family Are Expressed in Sweat and Sebaceous Glands of Human Fetal and Adult SkinJournal of Investigative Dermatology, 1996
- Over‐expression of p53 protein as an indicator of the malignant transformation in spiradenomaHistopathology, 1995
- Carcinosarcoma Arising in Eccrine SpiradenomaThe American Journal of Dermatopathology, 1990
- Sweat Gland Carcinoma Ex Eccrine SpiradenomaThe American Journal of Dermatopathology, 1987
- Mitotic figures in sweat gland adenomasJournal of Cutaneous Pathology, 1987
- Expression of differentiation antigens in benign sweat gland tumoursBritish Journal of Dermatology, 1984